ADMO

ADMO formalizes Alzheimer's disease molecular knowledge using the Disease Map Ontology (DMO) to store, link, and interpret multi-omics biomedical data and molecular pathways.

Key Features:

• Ontology-Based Framework: Built on Disease Map Ontology (DMO) with axiomatic definitions and logical reasoning properties to enhance expressiveness, reduce ambiguities, and improve interoperability with other knowledge resources.
• Integration of Multi-Omics Data: Manages and stores multi-omics biomedical data to support integrated analyses of molecular entities and pathways.
• Redundancy and Consistency Management: Addresses redundancy, naming conventions, consistency, process classification, and pathway relationships within disease maps to ensure coherent representation of molecular interactions.
• Enriched Model - ADMO-plus: Expands the ontology by incorporating additional elements, including clinical features from the AD Ontology, to link molecular and clinical data.
• Interoperability and Knowledge Integration: Converts AlzPathway into a formal ontology to enhance interoperability with other biomedical knowledge bases and enable linkage of curated disease-map knowledge.

Scientific Applications:

• Explore Molecular Pathways: Maps molecular interactions and pathways in Alzheimer's disease to support identification of mechanistic relationships and potential therapeutic targets.
• Facilitate Data Integration: Provides an ontological framework for integrating heterogeneous omics and clinical datasets to enable cross-study analyses.
• Support Predictive Modeling: Supplies structured molecular and clinical knowledge to inform development of predictive models of disease progression and treatment response.

Methodology:

Converting curated knowledge from AlzPathway into a formal ontology using DMO principles; curating molecular pathways; applying ontological structuring to ensure logical consistency, reduce redundancy, and enhance expressiveness; integrating clinical features from the AD Ontology to create ADMO-plus.